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Introduction
HTLV-1 is associated with the development of HAM/
TSP and overactive bladder (OB). A higher prevalence
of helminthic coinfection has been observed among
those infected with HTLV-1. Because helminthic infec-
tion may modify the immune response and influence
clinical outcomes in HTLV-1 infection, we investigated
the development of HAM/TSP and OB in HTLV-1 posi-
tive individuals with and without helminthic coinfection.
Methods
HTLV-1 patients enrolled in a cohort study between
2004-2010 were classified as coinfected and non-coin-
fected based on stool samples. All patients were fol-
lowed at least two years from initial evaluation, with
yearly clinical assessments. Disease-free survival for OB
was estimated using the Kaplan-Meier method, and the
relationship between helminthic infection and develop-
ment of OB was assessed by Cox proportional hazard
modeling.
Results
Seventy-four coinfected and 79 non-coinfected patients
were followed. A total of 92 helminthic infections were
observed in the coinfected group. One patient from
each group developed HAM/TSP during followup. Four-
teen and 17 patients developed OB from the coinfected
and non-coinfected groups, respectively. There was no
association between helminthic infection and risk of OB
(hazard ratio 0.91, 95% CI 0.43-1.89, p = 0.79, adjusted
for sex).
Discussion
We found no difference in the risk of development of
OB in HTLV-1 and helminthic coinfected and non-coin-
fected patients. The incidence of HAM/TSP was low in
each group. These data indicate that general helminthic
infection does not modify development of HAM/TSP or
OB. Future studies should address the potential associa-
tion between specific helminthic infections and risk of
neurologic disease in HTLV-1 infection.
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